A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report
TFE3-rearranged renal cell carcinoma (RCC) is a rare subtype of renal tumor that primarily affects young women and is characterized by early metastasis and a poor prognosis. This case study presents a 29-year-old woman diagnosed with TFE3-rearranged RCC, who initially presented with painless gross h...
Main Authors: | Haiyang Yang, Xiang Dong, Xinghe Pan, Wenliang Ma, Jun Pan, Hongqian Guo, Weidong Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1252282/full |
Similar Items
-
Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
by: Ning Liu, et al.
Published: (2022-04-01) -
Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
by: Xiang Dong, et al.
Published: (2022-10-01) -
Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
by: Wei Guo, et al.
Published: (2023-02-01) -
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
by: Audrey Simonaggio, et al.
Published: (2022-07-01) -
Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
by: Yan Ge, et al.
Published: (2021-11-01)